SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Livzon Pharmaceutical Group Inc. (1513.HK) News

Track canonical SquawkNews coverage tagged to 1513.HK, Livzon Pharmaceutical Group Inc.. This hub brings together deduplicated headlines about hkse, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol 1513.HK Asset equity Sector Markets 90 days 1 Last 21.94 Updated Sep 29, 2026, 03:27 PM UTC Open live news feed
M Livzon Pharmaceutical unit gets NMPA approval for leuprorelin acetate microspheres injection Reuters reports the unit received an NMPA drug supplementary application approval notice for leuprorelin acetate microspheres for injection 11.25mg (3-month formulation). EQUITY | Sep 29, 2026, 03:27 PM UTC